Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kazuyuki Kano"'
Publikováno v:
BMC Musculoskeletal Disorders, Vol 23, Iss 1, Pp 1-11 (2022)
Abstract Background To evaluate the efficacy and safety of intra-articular injection of diclofenac etalhyaluronate (DF-HA) in patients with osteoarthritis (OA) of the hip, ankle, shoulder, or elbow. Methods In this randomized, placebo-controlled, dou
Externí odkaz:
https://doaj.org/article/0db5c5d5df4945d5a864fe065aa9250e
Publikováno v:
BMC Musculoskeletal Disorders, Vol 22, Iss 1, Pp 1-11 (2021)
Abstract Background We evaluated the 1-year safety and efficacy of diclofenac etalhyaluronate (DF-HA), a diclofenac-conjugated hyaluronate, in patients with osteoarthritis (OA). Methods In this multi-centre, open-label, noncomparative phase 3 study i
Externí odkaz:
https://doaj.org/article/8c3cc56c7db84a3883bc25b08d4d83a0
Publikováno v:
Arthritis & Rheumatology (Hoboken, N.j.)
OBJECTIVE To confirm the efficacy and safety of intraarticular (IA) injection of diclofenac covalently linked to hyaluronic acid (diclofenac etalhyaluronate [DF-HA]; ONO-5704/SI-613) in patients with knee osteoarthritis (OA). METHODS In a phase III m
Publikováno v:
Rheumatology (Oxford, England)
Objective To evaluate the efficacy and safety of diclofenac etalhyaluronate (DF-HA) (ONO-5704/SI-613), a novel DF-conjugated hyaluronate, in patients with knee OA in Japan. Methods In this randomized, double-blind, placebo-controlled phase 2 study, p
Publikováno v:
BMC musculoskeletal disorders. 23(1)
Background To evaluate the efficacy and safety of intra-articular injection of diclofenac etalhyaluronate (DF-HA) in patients with osteoarthritis (OA) of the hip, ankle, shoulder, or elbow. Methods In this randomized, placebo-controlled, double-blind
Publikováno v:
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders, Vol 22, Iss 1, Pp 1-11 (2021)
BMC Musculoskeletal Disorders, Vol 22, Iss 1, Pp 1-11 (2021)
Background We evaluated the 1-year safety and efficacy of diclofenac etalhyaluronate (DF-HA), a diclofenac-conjugated hyaluronate, in patients with osteoarthritis (OA). Methods In this multi-centre, open-label, noncomparative phase 3 study in Japan,
Publikováno v:
Arthritis & Rheumatology (Hoboken, N.j.)
Autor:
Kubo, Toshikazu1 (AUTHOR), Kumai, Tsukasa2 (AUTHOR), Ikegami, Hiroyasu3 (AUTHOR), Kano, Kazuyuki4 (AUTHOR), Nishii, Megumi4 (AUTHOR), Seo, Takayuki4 (AUTHOR) clin_6131033@seikagaku.co.jp
Publikováno v:
BMC Musculoskeletal Disorders. 4/20/2022, Vol. 23 Issue 1, p1-11. 11p.
Publikováno v:
Arthritis & Rheumatology; Dec2021, Vol. 73 Issue 12, p2361-2385, 25p
Publikováno v:
Arthritis & Rheumatology; Sep2021, Vol. 73 Issue 9, p1646-1655, 10p